This clinical trial will evaluate the growth, tolerance, and iron status of infants who consume an investigational infant formula containing a nutrient-rich whey protein compared to a previously marketed infant formula.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Enrollment
373
Birmingham Pediatric Associates
Birmingham, Alabama, United States
Body weight measured at each study visit
Measurement collected with a calibrated infant scale
Time frame: 12 months
Body length measured at each study visit
Measurement collected with a standardized length board
Time frame: 12 months
Head circumference measured at each study visit
Measurement collected with a standardized measuring tape
Time frame: 12 months
Parental recall of study formula intake at each study visit
Time frame: 12 months
Parental recall of stool consistency measured at each study visit
Time frame: 12 months
Blood Collection
Composite measure of hemoglobin, hematocrit, ferritin, and c-reactive protein
Time frame: Once at 12 months
Medically-confirmed adverse events collected throughout the study period
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Southeastern Pediatric Associates
Dothan, Alabama, United States
Pediatrics East - Alabama Clinical Therapeutics
Pinson, Alabama, United States
Northwest Arkansas Pediatric Clinic
Fayetteville, Arkansas, United States
The Children's Clinic of Jonesboro, P.A.
Jonesboro, Arkansas, United States
Norwich Pediatric Group, P.C.
Norwich, Connecticut, United States
Children's Research, LLC
Altamonte Springs, Florida, United States
Deaconess Clinical Research
Evansville, Indiana, United States
Heartland Research Associates, LLC
Augusta, Kansas, United States
Heartland Research Associates, LLC
Newton, Kansas, United States
...and 12 more locations